Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 540

1.

AmpC β-lactamases in nosocomial isolates of Klebsiella pneumoniae from India.

Gupta V, Kumarasamy K, Gulati N, Garg R, Krishnan P, Chander J.

Indian J Med Res. 2012 Aug;136(2):237-41.

2.
3.
4.

Prevalent phenotypes and antibiotic resistance in Escherichia coli and Klebsiella pneumoniae at an Indian tertiary care hospital: plasmid-mediated cefoxitin resistance.

Shahid M, Malik A, Akram M, Agrawal LM, Khan AU, Agrawal M.

Int J Infect Dis. 2008 May;12(3):256-64. Epub 2007 Nov 5.

5.

An Increase in the clinical isolation of acquired AmpC β-lactamase-producing Klebsiella pneumoniae in Korea from 2007 to 2010.

Park MJ, Kim TK, Song W, Kim JS, Kim HS, Lee J.

Ann Lab Med. 2013 Sep;33(5):353-5. doi: 10.3343/alm.2013.33.5.353. Epub 2013 Aug 8.

6.

Occurrence of ESBL & Amp-C beta-lactamases & susceptibility to newer antimicrobial agents in complicated UTI.

Taneja N, Rao P, Arora J, Dogra A.

Indian J Med Res. 2008 Jan;127(1):85-8.

PMID:
18316858
7.
8.

Detection of plasmid-mediated AmpC β-lactamase in Escherichia coli and Klebsiella pneumoniae.

Yilmaz NO, Agus N, Bozcal E, Oner O, Uzel A.

Indian J Med Microbiol. 2013 Jan-Mar;31(1):53-9. doi: 10.4103/0255-0857.108723.

9.

Evaluation of methods for AmpC beta-lactamase in gram negative clinical isolates from tertiary care hospitals.

Singhal S, Mathur T, Khan S, Upadhyay DJ, Chugh S, Gaind R, Rattan A.

Indian J Med Microbiol. 2005 Apr;23(2):120-4.

10.
11.

[Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].

Susić E.

Acta Med Croatica. 2004;58(4):307-12. Croatian.

PMID:
15700687
13.

Clonal spread of both oxyimino-cephalosporin- and cefoxitin-resistant Klebsiella pneumoniae isolates co-producing SHV-2a and DHA-1 beta-lactamase at a burns intensive care unit.

Song W, Lee KM, Kim HS, Kim JS, Kim J, Jeong SH, Roh KH.

Int J Antimicrob Agents. 2006 Dec;28(6):520-4. Epub 2006 Nov 13.

PMID:
17095195
14.

Phenotypic & molecular characterization of AmpC β-lactamases among Escherichia coli, Klebsiella spp. & Enterobacter spp. from five Indian Medical Centers.

Manoharan A, Sugumar M, Kumar A, Jose H, Mathai D, Khilnani GC, Kapil A, Francis G, Radhakrishnan K, Dutta TK, Parija SC, Narang R, Mendiratta DK, Deotale V, Baronia AK, Prasad KN.

Indian J Med Res. 2012 Mar;135:359-64.

15.

Characterization of clinical isolates of Klebsiella pneumoniae from 19 laboratories using the National Committee for Clinical Laboratory Standards extended-spectrum beta-lactamase detection methods.

Steward CD, Rasheed JK, Hubert SK, Biddle JW, Raney PM, Anderson GJ, Williams PP, Brittain KL, Oliver A, McGowan JE Jr, Tenover FC.

J Clin Microbiol. 2001 Aug;39(8):2864-72.

17.

AmpC beta-lactamase producing bacterial isolates from Kolkata hospital.

Arora S, Bal M.

Indian J Med Res. 2005 Sep;122(3):224-33.

PMID:
16251779
20.

Cefepime and the inoculum effect in tests with Klebsiella pneumoniae producing plasmid-mediated AmpC-type beta-lactamase.

Kang CI, Pai H, Kim SH, Kim HB, Kim EC, Oh MD, Choe KW.

J Antimicrob Chemother. 2004 Dec;54(6):1130-3. Epub 2004 Oct 14.

PMID:
15486080

Supplemental Content

Support Center